| Ramipril |
20050133 |
Vivace, Tablet, 10, mg, Pack: 30 |
Актавис EАД, България |
Балканфарма Дупница АД България; Actavis hf., Исландия, Actavis Ltd Malta |
6.96 |
1.39 |
8.35 |
7% |
0.49 |
7.45 |
1.49 |
8.94 |
20% |
1.39 |
8.84 |
1.77 |
10.61 |
|
КЦРР-2378/21.02.2013 |
08.03.2013 |
08.03.2013 |
Неактивен |
1659 |
| Ramipril |
20050133 |
Vivace, Tablet, 5, mg, Pack: 30 |
Актавис EАД, България |
Балканфарма Дупница АД България; Actavis hf., Исландия, Actavis Ltd Malta |
3.58 |
0.72 |
4.3 |
7% |
0.25 |
3.83 |
0.77 |
4.6 |
20% |
0.72 |
4.55 |
0.91 |
5.46 |
|
КЦРР-2373/21.02.2013 |
08.03.2013 |
08.03.2013 |
Неактивен |
3847 |
| Ramipril |
2165/28,05,2008, |
Vivace, Tablet, 10, mg, Pack: 30 |
Актавис EАД, България |
Балканфарма- Дупница АД; Actavis Ltd, Malta;Actavis hf.,Iceland |
9.33 |
1.87 |
11.2 |
7% |
0.65 |
9.98 |
2 |
11.98 |
20% |
1.87 |
11.85 |
2.37 |
14.22 |
|
КЦ-279/14.11.2008 |
11.12.2008 |
11.12.2008 |
Неактивен |
1659 |
| Ramipril |
11856/14.11.2005 |
Vivace, Tablet, 5, mg, Pack: 30 |
Актавис EАД, България |
Балканфарма- Дупница АД; Actavis Ltd, Malta;Actavis hf.,Iceland |
6 |
1.2 |
7.2 |
7% |
0.42 |
6.42 |
1.28 |
7.7 |
20% |
1.2 |
7.62 |
1.52 |
9.14 |
|
КЦ-279/14.11.2008 |
11.12.2008 |
11.12.2008 |
Неактивен |
3847 |
| Ramipril, Amlodipine |
20150269 |
Vivace Duo, Capsule, hard, 10 mg/10 mg, mg, Pack: 30 |
Actavis Group PTC ehf., Исландия |
Zaklad Farmaceutyczny Adamed Pharma S.A., Полша; Pabianickie Zaklady Farmaceutyczne Polfa S.A., Полша |
9.51 |
1.9 |
11.41 |
7% |
0.67 |
10.18 |
2.04 |
12.22 |
20% |
1.9 |
12.08 |
2.42 |
14.5 |
|
НСР-7275/21.10.2015. |
05.11.2015 |
05.11.2015 |
Активен |
4087 |
| Ramipril, Amlodipine |
20150266 |
Vivace Duo, Capsule, hard, 5 mg/5 mg, mg, Pack: 30 |
Actavis Group PTC ehf., Исландия |
Zaklad Farmaceutyczny Adamed Pharma S.A., Полша; Pabianickie Zaklady Farmaceutyczne Polfa S.A., Полша |
7.2 |
1.44 |
8.64 |
7% |
0.5 |
7.7 |
1.54 |
9.24 |
20% |
1.44 |
9.14 |
1.83 |
10.97 |
|
НСР-7275/21.10.2015. |
05.11.2015 |
05.11.2015 |
Активен |
4085 |
| Ramipril, Amlodipine |
20150268 |
Vivace Duo, Capsule, hard, 10 mg/5 mg, mg, Pack: 30 |
Actavis Group PTC ehf., Исландия |
Zaklad Farmaceutyczny Adamed Pharma S.A., Полша; Pabianickie Zaklady Farmaceutyczne Polfa S.A., Полша |
8.64 |
1.73 |
10.37 |
7% |
0.6 |
9.24 |
1.85 |
11.09 |
20% |
1.73 |
10.97 |
2.19 |
13.16 |
|
НСР-7275/21.10.2015. |
05.11.2015 |
05.11.2015 |
Активен |
4086 |
| Ambrisentan |
EU/1/08/451/002 |
VOLIBRIS, Film coated tablet, 5, mg, Pack: 30 |
Glaxo Group Ltd., Обединено Кралство |
Aspen Bad Oldesloe GmbH, Germany |
3411.36 |
682.27 |
4093.63 |
4% |
10 |
3421.36 |
684.27 |
4105.63 |
16% |
25 |
3446.36 |
689.27 |
4135.63 |
|
HCР-5279/11.12.2014; НСР-10029/18.08.2016 |
02.10.2016 |
02.10.2016 |
Активен |
3414 |
| Ambrisentan |
EU/1/08/451/002 |
VOLIBRIS, Film coated tablet, 5, mg, Pack: 30 |
Glaxo Group Ltd., Обединено Кралство |
Aspen Bad Oldesloe GmbH, Germany |
3590.9 |
718.18 |
4309.08 |
4% |
10 |
3600.9 |
720.18 |
4321.08 |
16% |
25 |
3625.9 |
725.18 |
4351.08 |
|
HCР-5279/11.12.2014 |
11.12.2014 |
11.12.2014 |
Неактивен |
3414 |
| Ambrisentan |
EU/1/08/451/002 |
VOLIBRIS, Film coated tablet, 5, mg, Pack: 30 |
Glaxo Group Ltd., Обединено Кралство |
Glaxo Wellcome GmbH&CO. KG GERMANY |
3790.34 |
758.07 |
4548.41 |
4% |
10 |
3800.34 |
760.07 |
4560.41 |
16% |
25 |
3825.34 |
765.07 |
4590.41 |
|
HCР-4643/25.09.2014 |
09.10.2014 |
09.10.2014 |
Неактивен |
3414 |
| Ambrisentan |
EU/1/08/451/002 |
VOLIBRIS, Film coated tablet, 5, mg, Pack: 30 |
Glaxo Group Ltd., Обединено Кралство |
Glaxo Wellcome GmbH&CO. KG GERMANY |
3843.91 |
768.78 |
4612.69 |
4% |
10 |
3853.91 |
770.78 |
4624.69 |
16% |
25 |
3878.91 |
775.78 |
4654.69 |
|
HCР-305/03.07.2013. |
17.07.2013 |
17.07.2013 |
Неактивен |
3414 |
| Ambrisentan |
EU/1/08/451/002 |
VOLIBRIS, Film coated tablet, 5, mg, Pack: 30 |
Glaxo Group Ltd., Обединено Кралство |
Glaxo Wellcome GmbH&CO. KG GERMANY |
4040.1 |
808.02 |
4848.12 |
4% |
10 |
4050.1 |
810.02 |
4860.12 |
16% |
25 |
4075.1 |
815.02 |
4890.12 |
|
КЦ-2269/01.06.2011 |
15.06.2011 |
15.06.2011 |
Неактивен |
3414 |
| Diclofenac |
1043/19.11.2007 г. |
VOLTAREN 75 MG/3 ML, Solution for injection, 25 mg/ml - 3 ml, mg, Pack: 5 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Германия |
3.11 |
0.62 |
3.73 |
7% |
0.22 |
3.33 |
0.67 |
4 |
20% |
0.62 |
3.95 |
0.79 |
4.74 |
цената е заличена с решение НСР-951/12.08.2013 |
КЦ-531/19.02.2009 |
13.03.2009 |
13.03.2009 |
Заличен |
528 |
| Hydroxyethylstarch |
20110163/14.03.2011. |
Volulyte 6%, Solution for infusion, 500, ml, Pack: 1 |
Фрезениус Каби България ЕООД, България |
Frezenius Kabi Austria GmbH, Fresenius Kabi Deutschland GmbH, |
12.15 |
2.43 |
14.58 |
6% |
0.73 |
12.88 |
2.58 |
15.46 |
18% |
2.19 |
15.07 |
3.01 |
18.08 |
|
НСР-5289/ 18.12.2014. |
01.01.2015 |
01.01.2015 |
Активен |
3479 |
| Hydroxyethylstarch |
20110163/14.03.2011. |
Volulyte 6%, Solution for infusion, 500, ml, Pack: 1 |
Фрезениус Каби България ЕООД, България |
Frezenius Kabi Austria GmbH, Fresenius Kabi Deutschland GmbH, |
13.14 |
2.63 |
15.77 |
6% |
0.79 |
13.93 |
2.79 |
16.72 |
18% |
2.37 |
16.3 |
3.26 |
19.56 |
корекц. решение КЦPP-1611/05.11.2012 |
КЦРР-1413/05.09.2012 |
05.10.2012 |
05.10.2012 |
Неактивен |
3479 |
| Hydroxyethylstarch |
ІІ-1342/28.12.2007 г. |
Voluven, Solution for infusion, 500, ml, Pack: 1 |
Fresenius Kabi Deutschland GmbH, Германия |
Fresenius Kabi Deutschland GmbH, D-61346 Bad Homburg v.d.H., Germany Fresenius Kabi France, 6 rue du Rempart, B.P. 611, 27400 Louviers Cedex, France / Fresenius Kabi Polska Sp. Z.o.o., Wytwornia Plynow Infuzyjnych, 25 Sienkiewicza Street, 99-300 Kutno, Poland |
15.39 |
3.08 |
18.47 |
6% |
0.92 |
16.31 |
3.26 |
19.57 |
18% |
2.77 |
19.08 |
3.82 |
22.9 |
|
КЦ-1015/02.07.2009 |
16.07.2009 |
16.07.2009 |
Неактивен |
792 |
| Hydroxyethylstarch |
20120381/ 02.08.2012 |
Voluven 10%, Solution for infusion, 500 ml, -, Pack: 10 bottle |
Фрезениус Каби България ЕООД, България |
Fresenius Kabi Deutscland GmbH, 61346 Bad Homburg v.d.H., Германия |
194.51 |
38.9 |
233.41 |
4% |
7.78 |
202.29 |
40.46 |
242.75 |
16% |
25 |
227.29 |
45.46 |
272.75 |
|
КЦРР-2748/20.03.2013 |
19.04.2013 |
19.04.2013 |
Активен |
1771 |
| Hydroxyethylstarch |
20120381/ 02.08.2012 |
Voluven 10%, Solution for infusion, 500, ml, Pack: 10 |
Фрезениус Каби България ЕООД, България |
Fresenius Kabi Deutscland GmbH, 61346 Bad Homburg v.d.H., Германия |
194.51 |
38.9 |
233.41 |
4% |
7.78 |
202.29 |
40.46 |
242.75 |
16% |
25 |
227.29 |
45.46 |
272.75 |
|
КЦРР-2748/20.03.2013 |
19.04.2013 |
19.04.2013 |
Неактивен |
1771 |
| Hydroxyethylstarch |
ІІ-1342/28.12.2007 г. |
Voluven 6%, Solution for infusion, 500 ml, -, Pack: 1 bottle |
Fresenius Kabi Deutschland GmbH, Германия |
Fresenius Kabi Deutschland GmbH, D-61346 Bad Homburg v.d.H., Germany Fresenius Kabi France, 6 rue du Rempart, B.P. 611, 27400 Louviers Cedex, France / Fresenius Kabi Polska Sp. Z.o.o., Wytwornia Plynow Infuzyjnych, 25 Sienkiewicza Street, 99-300 Kutno, Poland |
12.22 |
2.44 |
14.66 |
6% |
0.73 |
12.95 |
2.59 |
15.54 |
18% |
2.2 |
15.15 |
3.03 |
18.18 |
|
НСР-7205/09.10.2015. |
24.10.2015 |
24.10.2015 |
Активен |
792 |
| Voriconazole |
EU/1/13/835/002 |
Voriconazole, Film coated tablet, 50, mg, Pack: 10 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено кралство |
150.19 |
30.04 |
180.23 |
4% |
6.01 |
156.2 |
31.24 |
187.44 |
16% |
24.03 |
180.23 |
36.05 |
216.28 |
|
НСР-4561/03.09.2014 |
16.12.2014 |
16.12.2014 |
Активен |
3385 |
| Voriconazole |
EU/1/13/835/002 |
Voriconazole, Film coated tablet, 50, mg, Pack: 10 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено кралство |
150.19 |
30.04 |
180.23 |
4% |
6.01 |
156.2 |
31.24 |
187.44 |
16% |
24.03 |
180.23 |
36.05 |
216.28 |
|
НСР-4561/03.09.2014 |
16.12.2014 |
16.12.2014 |
Неактивен |
3385 |
| Voriconazole |
EU/1/13/835/011 |
Voriconazole, Film coated tablet, 200, mg, Pack: 10 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено кралство |
600.01 |
120 |
720.01 |
4% |
10 |
610.01 |
122 |
732.01 |
16% |
25 |
635.01 |
127 |
762.01 |
|
НСР-4561/03.09.2014 |
16.12.2014 |
16.12.2014 |
Активен |
3384 |
| Voriconazole |
EU/1/13/835/011 |
Voriconazole, Film coated tablet, 200, mg, Pack: 10 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено кралство |
600.01 |
120 |
720.01 |
4% |
10 |
610.01 |
122 |
732.01 |
16% |
25 |
635.01 |
127 |
762.01 |
|
НСР-4561/03.09.2014 |
16.12.2014 |
16.12.2014 |
Неактивен |
3384 |
| Voriconazole |
20160171 |
Voriconazole Actavis, Powder for solution for infusion, 200, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C. Sindan Pharma SRL, Румъния; Actavis Italy S.p.a., Nerviano Plant, Италия |
145.12 |
29.02 |
174.14 |
4% |
5.8 |
150.92 |
30.18 |
181.1 |
16% |
23.22 |
174.14 |
34.83 |
208.97 |
|
НСР-9976/16.08.2016 |
02.09.2016 |
02.09.2016 |
Активен |
15145 |
| Voriconazole |
20140124 |
Voriconazole Sandoz, Powder for solution for infusion, 200, mg, Pack: 1 |
Sandoz d.d., Словения |
Lek Pharmaceuticals d.d., Словения; Salutas Pharma GmbH, Германия |
145.12 |
29.02 |
174.14 |
4% |
5.8 |
150.92 |
30.18 |
181.1 |
16% |
23.22 |
174.14 |
34.83 |
208.97 |
|
НСР-5759/26.02.2015. |
12.03.2015 |
12.03.2015 |
Активен |
3622 |